These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 26683902)

  • 1. Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease.
    Hou L; Kim JJ; Woo YJ; Huang NF
    Am J Physiol Heart Circ Physiol; 2016 Feb; 310(4):H455-65. PubMed ID: 26683902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic angiogenesis of adipose-derived stem cells for ischemic diseases.
    Zhao L; Johnson T; Liu D
    Stem Cell Res Ther; 2017 Jun; 8(1):125. PubMed ID: 28583178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cell-based therapeutic angiogenesis for the treatment of ischemic disease].
    Hamano K; Li TS
    Nihon Geka Gakkai Zasshi; 2004 Aug; 105(8):464-8. PubMed ID: 15373224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial progenitor cells: regulation and contribution to adult neovascularization.
    Walter DH; Dimmeler S
    Herz; 2002 Nov; 27(7):579-88. PubMed ID: 12439630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments.
    Templin C; Lüscher TF; Landmesser U
    Int J Dev Biol; 2011; 55(4-5):407-17. PubMed ID: 21553380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia.
    Kawamoto A; Tkebuchava T; Yamaguchi J; Nishimura H; Yoon YS; Milliken C; Uchida S; Masuo O; Iwaguro H; Ma H; Hanley A; Silver M; Kearney M; Losordo DW; Isner JM; Asahara T
    Circulation; 2003 Jan; 107(3):461-8. PubMed ID: 12551872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow-derived stem cell therapy in ischemic heart disease.
    Cho HJ; Lee J; Wecker A; Yoon YS
    Regen Med; 2006 May; 1(3):337-45. PubMed ID: 17465787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic angiogenesis for peripheral arterial disease and ischemic heart disease by autologous bone marrow cells implantation].
    Tatsumi T; Matsubara H
    Nihon Rinsho; 2006 Nov; 64(11):2126-34. PubMed ID: 17087307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous adipose tissue as a new source of progenitor cells for therapeutic angiogenesis.
    Murohara T
    J Cardiol; 2009 Apr; 53(2):155-63. PubMed ID: 19304117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease.
    Ripa RS
    Dan Med J; 2012 Mar; 59(3):B4411. PubMed ID: 22381094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to therapeutic angiogenesis for ischemic heart disease.
    Johnson T; Zhao L; Manuel G; Taylor H; Liu D
    J Mol Med (Berl); 2019 Feb; 97(2):141-151. PubMed ID: 30554258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of endothelial progenitor cells for therapeutic neovascularization.
    Kawamoto A; Asahara T; Losordo DW
    Cardiovasc Radiat Med; 2002; 3(3-4):221-5. PubMed ID: 12974378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current status of stem cell therapy in ischemic heart disease.
    Michler RE
    J Card Surg; 2018 Sep; 33(9):520-531. PubMed ID: 30136308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges.
    Tongers J; Losordo DW; Landmesser U
    Eur Heart J; 2011 May; 32(10):1197-206. PubMed ID: 21362705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Umbilical Cord-Derived Mesenchymal Stem Cells Relieve Hind Limb Ischemia by Promoting Angiogenesis in Mice.
    Wang Z; Zheng L; Lian C; Qi Y; Li W; Wang S
    Stem Cells Dev; 2019 Oct; 28(20):1384-1397. PubMed ID: 31407635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic angiogenesis with bone marrow--derived stem cells.
    Tse HF; Lau CP
    J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):89-97. PubMed ID: 17562779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD133+ cell as advanced medicinal product for myocardial and limb ischemia.
    Bongiovanni D; Bassetti B; Gambini E; Gaipa G; Frati G; Achilli F; Scacciatella P; Carbucicchio C; Pompilio G
    Stem Cells Dev; 2014 Oct; 23(20):2403-21. PubMed ID: 25014242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Potential of Endothelial Colony-Forming Cells in Ischemic Disease: Strategies to Improve their Regenerative Efficacy.
    Faris P; Negri S; Perna A; Rosti V; Guerra G; Moccia F
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homing of progenitor cells to ischemic tissues.
    Chavakis E; Dimmeler S
    Antioxid Redox Signal; 2011 Aug; 15(4):967-80. PubMed ID: 20812875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic potential of progenitor cells in ischemic heart disease--Past, present and future.
    Hristov M; Weber C
    Basic Res Cardiol; 2006 Jan; 101(1):1-7. PubMed ID: 16382288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.